Retatrutide 20 mg pen
20 mg multiple use pen
Product Description
Looking for the cutting edge of peptide research? Retatrutide is one of the most advanced investigational compounds available today. With its unique triple-agonist action (GLP-1, GIP, and Glucagon receptors), it represents a new era in metabolic and weight-management research.
Why Researchers Choose Retatrutide:
✅ Triple receptor power – GLP-1, GIP, Glucagon pathways
✅ Metabolic innovation – fat metabolism & energy expenditure
✅ Promising body composition focus
✅ Lipidated structure for extended half-life
✅ High purity ≥99% (HPLC & MS verified)
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Retatrutide 20 mg pen
Retatrutide 20 mg pen
20 mg multiple use pen
Product Description
Looking for the cutting edge of peptide research? Retatrutide is one of the most advanced investigational compounds available today. With its unique triple-agonist action (GLP-1, GIP, and Glucagon receptors), it represents a new era in metabolic and weight-management research.
Why Researchers Choose Retatrutide:
✅ Triple receptor power – GLP-1, GIP, Glucagon pathways
✅ Metabolic innovation – fat metabolism & energy expenditure
✅ Promising body composition focus
✅ Lipidated structure for extended half-life
✅ High purity ≥99% (HPLC & MS verified)
Original: $183.80
-70%$183.80
$55.14Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
20 mg multiple use pen
Product Description
Looking for the cutting edge of peptide research? Retatrutide is one of the most advanced investigational compounds available today. With its unique triple-agonist action (GLP-1, GIP, and Glucagon receptors), it represents a new era in metabolic and weight-management research.
Why Researchers Choose Retatrutide:
✅ Triple receptor power – GLP-1, GIP, Glucagon pathways
✅ Metabolic innovation – fat metabolism & energy expenditure
✅ Promising body composition focus
✅ Lipidated structure for extended half-life
✅ High purity ≥99% (HPLC & MS verified)
